TRAW — Traws Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- $22.57m
- $19.44m
- $2.79m
Annual cashflow statement for Traws Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -16.2 | -19 | -18.9 | -167 | 9.17 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.255 | 1.17 | 1.3 | 143 | -25.8 |
| Unusual Items | |||||
| Purchased R&D | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -3.59 | 1.48 | -0.301 | -6.57 | -1.58 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -19.5 | -16.3 | -17.9 | -29.8 | -18.2 |
| Capital Expenditures | 0 | — | -0.014 | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | -3.65 | -2.58 |
| Acquisition of Business | |||||
| Cash from Investing Activities | 0 | — | -0.014 | -3.65 | -2.58 |
| Financing Cash Flow Items | — | — | — | — | -2.4 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 55.6 | 0 | — | 34 | 3.2 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 36 | -16.3 | -17.9 | 0.517 | -17.5 |